What is it about?
Cancer is a complex disease, and even within a single tumor, different regions may behave differently and respond differently to treatment. Understanding these differences is essential for developing more effective cancer therapies. Our review explores how mass spectrometry imaging (MSI), an advanced analytical technique, allows scientists to visualize the distribution of molecules such as proteins, fats (lipids), metabolites, and drugs directly within cancer tissues. Unlike conventional methods, MSI can provide detailed molecular information without requiring specific labels, helping researchers understand how tumors develop, interact with surrounding tissues, and respond to medicines. The article highlights recent advances in imaging technologies, including MALDI, DESI, and other emerging techniques, and explains their applications in cancer detection, biomarker discovery, and drug distribution studies. It also discusses how combining MSI with other molecular analysis techniques can provide a more complete picture of cancer biology. Ultimately, this review explains how MSI could contribute to earlier disease characterization, improved understanding of treatment resistance, and the development of more personalized approaches to cancer care.
Featured Image
Photo by CDC on Unsplash
Why is it important?
One of the major challenges in cancer treatment is that tumors are not uniform. Different regions of the same tumor may contain distinct molecular characteristics, influencing disease progression and responses to therapy. Conventional analytical approaches may overlook these spatial differences. Our review brings together recent technological advances in mass spectrometry imaging and examines how they can help overcome this challenge. By revealing where specific molecules and therapeutic drugs are located within tumor tissues, MSI offers valuable insights into cancer heterogeneity, treatment response, and potential mechanisms of drug resistance. A key contribution of this publication is its comparative evaluation of established and emerging MSI technologies, including their analytical capabilities, practical limitations, and potential integration with other molecular profiling approaches. The review also highlights important challenges involving analytical standardization, data interpretation, and clinical implementation. By connecting technological innovation with practical applications in oncology, this work provides researchers with a broader understanding of how MSI could support biomarker discovery, drug development, and future personalized cancer treatment strategies.
Perspectives
As a researcher working in pharmaceutical and bioanalytical sciences, I have always been interested in how advanced analytical technologies can contribute to a better understanding of diseases and improve therapeutic outcomes. Through this review, I wanted to explore how mass spectrometry imaging extends beyond conventional molecular analysis by revealing not only which molecules are present in cancer tissues, but also where they are distributed. I find this spatial dimension particularly valuable because understanding tumor heterogeneity and drug distribution is essential for advancing cancer research. What interests me most is the potential of MSI to connect analytical chemistry with cancer biology and personalized medicine. Although challenges remain before these technologies can be widely adopted in clinical practice, I believe continued advancements in imaging resolution, sensitivity, and integration with other molecular technologies will create important opportunities for cancer research. I hope this publication will help researchers, students, and professionals appreciate the growing role of mass spectrometry imaging in understanding cancer and developing more precise therapeutic strategies.
Dr. Erica Alves
Read the Original
This page is a summary of: Advancements in Mass Spectrometry Imaging for Cancer Research: From Tumor Profiling to Personalized Medicine, Current Analytical Chemistry, July 2026, Bentham Science Publishers,
DOI: 10.2174/0115734110401212250806053745.
You can read the full text:
Contributors
The following have contributed to this page
